Jay S. Duker
CIK 1630864 · President and CEO · last filed 2026-03-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.32M
Companies
4
Total Filings
40
Lifetime Open-Market Net
$29.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EYPT | President and CEO | 178,417 | $13.03 | $2.32M | $29.2K | 30 | 2026-03-24 |
| Carisma Therapeutics Inc. (SESN) Delisted | Director | 40,000 | $12.58 | $503.0K | $0 | 5 | 2022-06-24 |
| EyePoint, Inc. (PSDV) Delisted | Director | — | — | — | $0 | 2 | 2017-12-19 |
| Carisma Therapeutics Inc. (EBIO) Delisted | Director | — | — | — | $0 | 3 | 2017-05-23 |
Recent Filings · Page 4 of 4
40 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-04-16 | EYPT | Exer (M) | +20,000 | $35.4K | EDGAR |
| 2019-04-03 | EYPT | Buy (P) | +5,000 | $9.4K | EDGAR |
| 2018-06-29 | EYPT | Exer (M) | +12,500 | $0 | EDGAR |
| 2018-06-26 | EYPT | Grant (A) | — | $0 | EDGAR |
| 2018-06-14 | Carisma Therapeutics Inc. (SESN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-12-19 | EyePoint, Inc. (PSDV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-23 | Carisma Therapeutics Inc. (EBIO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-12-14 | EyePoint, Inc. (PSDV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-06-10 | Carisma Therapeutics Inc. (EBIO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-01-22 | Carisma Therapeutics Inc. (EBIO) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 31–40 of 40
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.